Deciphera Pharmaceuticals (DCPH) Insider Trading & Ownership

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)

$14.23

-0.49 (-3.33%)

(As of 04/18/2024 ET)

Current Insider Ownership Percentage: 4.43%
Number Of Insiders Buying (Last 12 Months): 2
Amount Of Insider Buying (Last 12 Months): $291,260.00
Number Of Insiders Selling (Last 12 Months): 4
Amount Of Insider Selling (Last 12 Months): $470,122.61

Get DCPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Deciphera Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DCPH Insider Buying and Selling by Quarter

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

Deciphera Pharmaceuticals Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
1/16/2024	Jama Pitman	SVP	Sell	1,624	$14.47	$23,499.28
1/16/2024	Matthew L Sherman	EVP	Sell	2,435	$14.47	$35,234.45
10/30/2023	Jama Pitman	Insider	Sell	1,407	$12.02	$16,912.14
10/30/2023	Matthew L Sherman	EVP	Sell	2,360	$12.02	$28,367.20
10/30/2023	Steven L Hoerter	CEO	Sell	21,573	$12.02	$259,307.46
10/30/2023	Thomas Patrick Kelly	CFO	Sell	2,316	$12.02	$27,838.32
Get Insider Trades Delivered To Your Inbox Enter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings.
10/2/2023	Matthew L Sherman	EVP	Sell	2,942	$12.68	$37,304.56
6/16/2023	Jama Pitman	Insider	Sell	1,238	$14.40	$17,827.20
6/16/2023	Matthew L Sherman	EVP	Sell	1,655	$14.40	$23,832.00
6/8/2023	Franklin Stuart Friedman	Director	Buy	10,000	$13.88	$138,800.00
5/10/2023	Dennis Leo Walsh	Director	Buy	11,000	$13.86	$152,460.00

(Data available from 1/1/2013 forward)

DCPH Insider Trading Activity - Frequently Asked Questions

Who is on Deciphera Pharmaceuticals's Insider Roster?: The list of insiders at Deciphera Pharmaceuticals includes Brightstar Associates Llc, Daniel C Martin, Daniel Lee Flynn, Dennis Leo Walsh, Franklin Stuart Friedman, Jama Pitman, James Arthur Bristol, Matthew L Sherman, Steven L Hoerter, and Thomas Patrick Kelly. Learn more on insiders at DCPH.
What percentage of Deciphera Pharmaceuticals stock is owned by insiders?: 4.43% of Deciphera Pharmaceuticals stock is owned by insiders. Learn more on DCPH's insider holdings.
Which Deciphera Pharmaceuticals insiders have been buying company stock?: The following insiders have purchased DCPH shares in the last 24 months: Brightstar Associates Llc ($44,789,768.00), Dennis Leo Walsh ($152,460.00), and Franklin Stuart Friedman ($138,800.00).

How much insider buying is happening at Deciphera Pharmaceuticals?: Insiders have purchased a total of 3,166,644 DCPH shares in the last 24 months for a total of $45,081,028.00 bought.
Which Deciphera Pharmaceuticals insiders have been selling company stock?: The following insiders have sold DCPH shares in the last 24 months: Daniel C Martin ($17,500.90), Daniel Lee Flynn ($51,039.72), Jama Pitman ($72,192.12), Matthew L Sherman ($206,860.82), Steven L Hoerter ($259,307.46), and Thomas Patrick Kelly ($48,525.32).
How much insider selling is happening at Deciphera Pharmaceuticals?: Insiders have sold a total of 56,606 Deciphera Pharmaceuticals shares in the last 24 months for a total of $772,201.34 sold.

More Insider Trading Tools from MarketBeat

Related Companies:

Insider Tracking Tools:

Insider Trading By Country:

Latest Articles:

This page (NASDAQ:DCPH) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Deciphera Pharmaceuticals (DCPH) Insider Trading & Ownership

DCPH Insider Buying and Selling by Quarter

Deciphera Pharmaceuticals Insider and Congressional Trades History

DCPH Insider Trading Activity - Frequently Asked Questions

More Insider Trading Tools from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Deciphera Pharmaceuticals (DCPH) Insider Trading & Ownership

Deciphera Pharmaceuticals (NASDAQ:DCPH) Insider Buying and Selling Activity

DCPH Insider Buying and Selling by Quarter

Deciphera Pharmaceuticals Insider and Congressional Trades History

DCPH Insider Trading Activity - Frequently Asked Questions

More Insider Trading Tools from MarketBeat